18/04/2015 12:45:29 Free Membership Login

Bristol Myers Sqibb News (NYSE:BMY)

DateTimeSource
Headline
04/16/20152:10PMDJNBristol-Myers to Sell Cancer Drug Rights to Eli Lilly
Bristol-Myers Squibb Co. said Thursday that it agreed to transfer North America commercialization rights of its cancer drug Erbitux to Eli Lilly & Co. The two pharmaceutical companies collaborated on the drug, which treats certain advanced colorectal, head and neck cancers, for 14 years. ImClone Systems Inc., which... More...>>
04/16/20151:58PMDJNBristol-Myers to Sell Cancer Drug Rights to Eli Lilly
By Lisa Beilfuss Bristol-Myers Squibb Co. said Thursday that it agreed to transfer North America commercialization rights of its cancer drug Erbitux to Eli Lilly & Co. The two pharmaceutical companies collaborated on the drug, which treats certain advanced colorectal, head and neck cancers, for 14 years. ImClone Systems... More...>>
04/16/201512:15PMBWLilly, Bristol-Myers Squibb Restructure Erbitux® (cetuximab) Collaboration in North America
Full Commercialization Rights Transferred to Lilly Eli Lilly and Company (NYSE:LLY) and Bristol-Myers Squibb Company (NYSE:BMY) today announced that the companies have agreed to transfer rights to Erbitux® (cetuximab) in North America, including the U.S., Canada, and Puerto Rico, from Bristol-Myers Squibb to Lilly. Rights... More...>>
04/16/20158:03AMTMFThe Best Stock to Invest in Hep C
http://www.fool.com/investing/general/2015/04/16/the-best-stock-to-invest-in-hep-c.aspx?source=eptadnlnk0000002 More...>>
04/14/20159:20AMSEEKHeat Biologics Is An Opportunity Among Soaring Immunotherapy Biotech Valuations
http://seekingalpha.com/article/3068836-heat-biologics-is-an-opportunity-among-soaring-immunotherapy-biotech-valuations?source=partner_advfn More...>>
04/14/20156:59AMTMF2 Speculative Biotechs That Could Be Well Worth the Risk
http://www.fool.com/investing/general/2015/04/14/2-speculative-biotechs-that-could-be-well-worth-th.aspx?source=eptadnlnk0000002 More...>>
04/12/20152:02PMSEEKJohnson & Johnson: Steadily Making Its Owners Richer
http://seekingalpha.com/article/3064366-johnson-and-johnson-steadily-making-its-owners-richer?source=partner_advfn More...>>
04/11/20151:03PMTMFThe Big Pharma Stock We'd Buy and Hold for the Next 20 Years
http://www.fool.com/investing/general/2015/04/11/the-big-pharma-stock-wed-buy-and-hold-for-the-next.aspx?source=eptadnlnk0000002 More...>>
04/11/20153:51AMSEEKImmunotherapy: Unleashing The Immune System To Decimate Cancer
http://seekingalpha.com/article/3063216-immunotherapy-unleashing-the-immune-system-to-decimate-cancer?source=partner_advfn More...>>
04/09/201510:35AMSEEKUniqure: Leveraging A €3M Acquisition Into A Nearly $300M Shareholder Gain
http://seekingalpha.com/article/3059426-uniqure-leveraging-a-3m-acquisition-into-a-nearly-300m-shareholder-gain?source=partner_advfn More...>>
04/08/20158:00AMBWBristol-Myers Squibb Completes Previously Announced Acquisition of Flexus Biosciences, Inc.
Bristol-Myers Squibb Company (NYSE:BMY) today announced that it has completed the previously announced planned acquisition of Flexus Biosciences, Inc. The transaction includes full rights to F001287, Flexus’ lead preclinical, small-molecule IDO1-inhibitor targeted for IND filing in the second half of 2015 and an IDO/TDO... More...>>
04/06/20155:54PMDJNBristol-Myers Invests in uniQure in Heart-Disease Pact -- 2nd Update
By Ron Winslow Bristol-Myers Squibb Co. agreed to invest in and co-develop gene-therapy medicines with the Dutch company uniQure NV, reflecting surging interest among major pharmaceutical companies in the treatment strategy. Under the agreement, Bristol-Myers will have exclusive rights to develop uniQure's gene remedies... More...>>
04/06/20152:48PMDJNBristol-Myers Invests in UniQure in Heart Disease Pact -- Update
By Angela Chen Bristol-Myers Squibb Co. agreed to invest in the Dutch company UniQure NV and work together on gene therapies for cardiovascular disease. Bristol-Myers will have exclusive access to the Dutch company's proprietary gene therapy program for congestive heart failure. The two companies will collaborate on 10... More...>>
04/06/20152:32PMDJNBristol-Myers Invests in UniQure in Heart Disease Pact
By Angela Chen Bristol-Myers Squibb Co. agreed to invest in the Dutch company UniQure NV and work together on gene therapies for cardiovascular disease. Bristol-Myers will have exclusive access to the Dutch company's proprietary gene therapy program for congestive heart failure. The two companies will collaborate on 10... More...>>
04/06/201510:35AMTMFWhy uniQure N.V. Stock Skyrocketed Today
http://www.fool.com/investing/general/2015/04/06/why-uniquire-nv-stock-skyrocketed-today.aspx?source=eptadnlnk0000002 More...>>
04/06/20158:12AMSEEKBristol-Myers and uniQure team up in cardiovascular diseases
http://seekingalpha.com/news/2410266-bristol-myers-and-uniqure-team-up-in-cardiovascular-diseases?source=partner_advfn More...>>
04/06/20157:32AMBWBristol-Myers Squibb & uniQure Enter into Exclusive Strategic Collaboration to Develop Gene Therapies for Cardiovascular Dise...
Bristol-Myers Squibb Company (NYSE:BMY) and uniQure N.V. (NASDAQ:QURE) announced today an agreement that provides Bristol-Myers Squibb with exclusive access to uniQure’s gene therapy technology platform for multiple targets in cardiovascular diseases. The collaboration includes uniQure’s proprietary gene therapy program... More...>>
04/05/20151:02PMTMFDisruptive Innovation Changing the Fight Against Cancer
http://www.fool.com/investing/general/2015/04/05/disruptive-innovation-changing-the-fight-against-c.aspx?source=eptadnlnk0000002 More...>>
04/05/20159:19AMTMFCould This Combo Therapy One Day Replace Chemotherapy?
http://www.fool.com/investing/general/2015/04/05/could-this-combo-therapy-one-day-replace-chemother.aspx?source=eptadnlnk0000002 More...>>
04/01/20158:14AMSEEKRoche looking for collaboration partners in cancer immunotherapies
http://seekingalpha.com/news/2404306-roche-looking-for-collaboration-partners-in-cancer-immunotherapies?source=partner_advfn More...>>


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

1 site:2 us nyse bmy150418 12:45